MedTrace Logo

Effect of Irvingia Gabonensis (Bush Mango)on Parameters Associated With Metabolic Syndrome

NCT00645775 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 102

Last updated 2008-03-28

No results posted yet for this study

Summary

The study investigated the use and efficacy of the seeds of African bush mango (Irvingia gabonensis)to control body weight, blood lipids and hormones in overweight and obese people.

Conditions

Interventions

DIETARY_SUPPLEMENT

IGOB131

Comparison of 250 mg per day of Irvingia gabonensis to placebo

Sponsors & Collaborators

  • University of Yaounde

    collaborator OTHER

  • Gateway Health Alliance

    lead INDUSTRY

Principal Investigators

  • Julius E Oben, PhD · Gateway Health Alliances / University of Yaounde

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-11-30
Primary Completion
2007-03-31
Completion
2007-04-30

Countries

  • Cameroon

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00645775 on ClinicalTrials.gov